Clinical Trials Directory

Trials / Completed

CompletedNCT02262351

Program for the Identification of "Actionable" Atrial Fibrillation in the Family Practice Setting

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2,174 (actual)
Sponsor
Population Health Research Institute · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

Atrial fibrillation (AF) is a major risk factor for stroke. The identification and treatment of AF is one of the best way to prevent stroke. The problem is that because AF may cause minimal symptoms, it often goes undetected before a patient suffers a stroke. Also, it is known that as many as half of all patients with known AF may not be receiving appropriate anticoagulation for their condition. New technologies are making it possible to improve AF detection. Subjects in this study will be screened for AF using three simple methods: a 30-second pulse check, a hand-held single-lead electrocardiogram (ECG) device and a blood pressure monitor with built-in AF screening capabilities. If more patients with AF can be detected, more patients will be able to receive guideline-recommended anticoagulant therapy, and more strokes, deaths, disability, and dementia will be prevented.

Detailed description

Participants will be screened for AF using three simple methods (pulse check, single-lead ECG, blood pressure machine with automated AF detection algorithms). Subjects screening positive on any test will attend for a 12-lead ECG within 24 h. For all patients with AF detected, clinical characteristics and medications will be compared at baseline and 90±14 days later.

Conditions

Interventions

TypeNameDescription
OTHER30 Second Pulse CheckTo detect atrial fibrillation
DEVICEWatch BP Home ABlood pressure device that detects atrial fibrillation
DEVICEHeartCheck Hand-held ECG deviceTo detect atrial fibrillation

Timeline

Start date
2015-04-01
Primary completion
2016-10-15
Completion
2016-12-02
First posted
2014-10-13
Last updated
2018-10-09

Locations

19 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT02262351. Inclusion in this directory is not an endorsement.